|
AGPS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.84710000522759E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.2252000000389E-06 |
| Normal-vs-Stage2 |
1.8362199999955E-05 |
| Normal-vs-Stage3 |
3.02889999970191E-07 |
| Normal-vs-Stage4 |
3.73880000292814E-08 |
| Stage1-vs-Stage2 |
4.041000E-01 |
| Stage1-vs-Stage3 |
1.877780E-01 |
| Stage1-vs-Stage4 |
3.497800E-02 |
| Stage2-vs-Stage3 |
8.908400E-01 |
| Stage2-vs-Stage4 |
2.976000E-01 |
| Stage3-vs-Stage4 |
3.127400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.61239999924612E-08 |
| Normal-vs-AfricanAmerican |
3.878300E-03 |
| Normal-vs-Asian |
2.0238999999922E-05 |
| Caucasian-vs-AfricanAmerican |
5.206200E-01 |
| Caucasian-vs-Asian |
8.319200E-01 |
| AfricanAmerican-vs-Asian |
4.548000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.67109999463733E-08 |
| Normal-vs-Female |
2.32889999951524E-07 |
| Male-vs-Female |
2.634600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.45989999999585E-05 |
| Normal-vs-Age(41-60Yrs) |
8.79179995472157E-09 |
| Normal-vs-Age(61-80Yrs) |
3.91870000004957E-07 |
| Normal-vs-Age(81-100Yrs) |
9.547700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.795600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.455800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.323600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.300000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.581000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.153000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.533800E-01 |
| Classical-VS-Follicular |
7.756000E-02 |
| Classical-VS-Other |
1.156630E-01 |
| Classical-VS-Normal |
1.8480000000265E-06 |
| Tall-VS-Follicular |
9.886000E-01 |
| Tall-VS-Other |
3.880200E-01 |
| Tall-VS-Normal |
1.365010E-04 |
| Follicular-VS-Other |
3.940600E-01 |
| Follicular-VS-Normal |
1.15570000003284E-06 |
| Other-VS-Normal |
1.395600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.69179999798664E-08 |
| Normal-vs-N1 |
1.63209999959335E-08 |
| N0-vs-N1 |
9.668300E-02 |
|
|
